Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination

Trial Profile

Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2014

At a glance

  • Drugs RIX 4414 (Primary)
  • Indications Rotavirus infections
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 13 Mar 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to completed.
    • 14 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top